自体造血干细胞移植治疗恶性血液病疗效观察

Journal of Shantou University Medical College(2014)

Cited 0|Views24
No score
Abstract
目的:评价自体造血干细胞移植(AHSCT)治疗恶性血液病的临床疗效.方法:回顾性分析我科行AHSCT治疗的38例恶性血液病患者的临床资料.结果:本组均成功重建造血,3、5年总生存率分别为(66.1±l1.6)%和(54.1±9.7)%,无病生存率分别为(61.1±12.3)%和(52.1±10.4)%.结论:AHSCT是一种治疗恶性血液病安全有效的方法.
More
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined